Sage Therapeutics Stock Soars 36% After Sale to Supernus Pharmaceuticals. What We Know.

Jun 16, 2025 - 15:26
 0
Sage Therapeutics Stock Soars 36% After Sale to Supernus Pharmaceuticals. What We Know.